First Large Case Series Regarding Stem Cell Reimplant Complications Published
We’re proud at Regenexx to announce the world’s first publication of a large, several year case series of patients treated with autologous mesenchymal stem cells and tracked prospectively for complications. The fact that no serious stem cell related complications were reported and the fact that the world’s highest definition MRI technology (3.0 Tesla imaging) was used to track more than 50 re-implant sites over time for tumor formation, makes this paper the first of it’s kind. No other clinic around the globe or even pharma sponsored group has published on anywhere near this number of cases followed for anywhere near this length of time. The upshot, cultured adult stem cells delivered through a needle for orthopedic applications in this large study were safer than the higher risk surgical procedures they helped many patients avoid.
If you have questions or comments about this blog post, please email us at [email protected]
NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.
